Pharma-Bio Serv Statistics
Total Valuation
Pharma-Bio Serv has a market cap or net worth of 14.90 million. The enterprise value is 4.24 million.
| Market Cap | 14.90M |
| Enterprise Value | 4.24M |
Important Dates
The next estimated earnings date is Thursday, January 29, 2026.
| Earnings Date | Jan 29, 2026 |
| Ex-Dividend Date | Feb 28, 2025 |
Share Statistics
Pharma-Bio Serv has 22.92 million shares outstanding. The number of shares has decreased by -0.08% in one year.
| Current Share Class | 22.92M |
| Shares Outstanding | 22.92M |
| Shares Change (YoY) | -0.08% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 54.95% |
| Owned by Institutions (%) | 1.49% |
| Float | 8.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.91 |
| PS Ratio | 1.62 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -50.36 |
| EV / Sales | 0.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.32 |
Financial Position
The company has a current ratio of 7.93, with a Debt / Equity ratio of 0.01.
| Current Ratio | 7.93 |
| Quick Ratio | 7.68 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -0.66% and return on invested capital (ROIC) is -3.18%.
| Return on Equity (ROE) | -0.66% |
| Return on Assets (ROA) | -2.75% |
| Return on Invested Capital (ROIC) | -3.18% |
| Return on Capital Employed (ROCE) | -5.52% |
| Revenue Per Employee | 122,464 |
| Profits Per Employee | -1,123 |
| Employee Count | 75 |
| Asset Turnover | 0.61 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -29,113 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.84% in the last 52 weeks. The beta is 0.80, so Pharma-Bio Serv's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | +4.84% |
| 50-Day Moving Average | 0.61 |
| 200-Day Moving Average | 0.55 |
| Relative Strength Index (RSI) | 54.84 |
| Average Volume (20 Days) | 4,568 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.90 |
Income Statement
In the last 12 months, Pharma-Bio Serv had revenue of 9.18 million and -84,250 in losses. Loss per share was -0.00.
| Revenue | 9.18M |
| Gross Profit | 2.89M |
| Operating Income | -658,520 |
| Pretax Income | -113,363 |
| Net Income | -84,250 |
| EBITDA | -608,543 |
| EBIT | -658,520 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 10.73 million in cash and 71,362 in debt, giving a net cash position of 10.65 million or 0.46 per share.
| Cash & Cash Equivalents | 10.73M |
| Total Debt | 71,362 |
| Net Cash | 10.65M |
| Net Cash Per Share | 0.46 |
| Equity (Book Value) | 11.93M |
| Book Value Per Share | 0.52 |
| Working Capital | 11.50M |
Cash Flow
In the last 12 months, operating cash flow was -416,127 and capital expenditures -163,309, giving a free cash flow of -579,436.
| Operating Cash Flow | -416,127 |
| Capital Expenditures | -163,309 |
| Free Cash Flow | -579,436 |
| FCF Per Share | -0.03 |
Margins
Gross margin is 31.44%, with operating and profit margins of -7.17% and -0.92%.
| Gross Margin | 31.44% |
| Operating Margin | -7.17% |
| Pretax Margin | -1.23% |
| Profit Margin | -0.92% |
| EBITDA Margin | -6.63% |
| EBIT Margin | -7.17% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 11.54%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 11.54% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.08% |
| Shareholder Yield | 11.62% |
| Earnings Yield | -0.57% |
| FCF Yield | -3.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pharma-Bio Serv has an Altman Z-Score of 7.16 and a Piotroski F-Score of 2.
| Altman Z-Score | 7.16 |
| Piotroski F-Score | 2 |